Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.54 |
| ▸ | TACR3 | P29371 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | DHODH | Q02127 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14907424 | 0.86 | LMNA (0.49) | ACHETACR3LMNASMN1; SMN2KDM4E | |
| SCHEMBL20414371 | 0.86 | ACHE (0.47) | ACHETACR3LMNASMN1; SMN2KDM4E | |
| SCHEMBL28697794 | 0.84 | TACR3 (0.52) | ACHETACR3LMNASMN1; SMN2KDM4E | |
| SCHEMBL18910858 | 0.83 | ACHE (0.56) | ACHETACR3LMNASMN1; SMN2KDM4E | |
| SCHEMBL22914905 | 0.81 | DHODH (0.58) | ACHELMNASMN1; SMN2KDM4EPDE10A | |
| SCHEMBL6218255 | 0.81 | TSHR (0.54) | ACHETACR3LMNASMN1; SMN2KDM4E | |
| SCHEMBL7221673 | 0.79 | ADORA2A (0.60) | ACHETACR3LMNASMN1; SMN2KDM4E | |
| SCHEMBL20414289 | 0.78 | ALDH1A1 (0.44) | TACR3LMNASMN1; SMN2KDM4EPDE10A | |
| SCHEMBL12768139 | 0.77 | ACHE (0.56) | ACHETACR3LMNASMN1; SMN2KDM4E | |
| SCHEMBL10868910 | 0.76 | CYP2D6 (0.49) | ACHELMNASMN1; SMN2KDM4EPDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8716265-B2 | 4-quinolinemethanols as anti-malarial agents | JENRIN DISCOVERY, INC. (US) | 2014-05-06 | — | — | US | disclosed |
| US-8716265-B2 | 4-quinolinemethanols as anti-malarial agents | JENRIN DISCOVERY, INC. (US) | 2014-05-06 | — | — | US | disclosed |
| US-20120178717-A1 | 4-QUINOLINEMETHANOLS AS ANTI-MALARIAL AGENTS | JENRIN DISCOVERY (US) | 2012-07-12 | — | — | US | disclosed |
| US-20120178717-A1 | 4-QUINOLINEMETHANOLS AS ANTI-MALARIAL AGENTS | JENRIN DISCOVERY (US) | 2012-07-12 | — | — | US | disclosed |
| WO-2012068560-A2 | 4-QUINOLINEMETHANOLS AS ANTI-MALARIAL AGENTS | JENRIN DISCOVERY (US) | 2012-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178717-A1 | 4-QUINOLINEMETHANOLS AS ANTI-MALARIAL AGENTS | CYP51A1, SQLE, NQO2 | ACHE 237/4885TACR3 2943/4885LMNA 1686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.